WSJ: Pfizer in talks with Seagen over purchase worth possibly over $30 billion
By Scott Kanowsky
Investing.com -- U.S. drug-making giant Pfizer Inc. (NYSE: PFE ) is in early-stage talks to acquire biotech Seagen Inc. (NASDAQ: SGEN ) in a deal that may potentially be worth more than $30 billion, according to the Wall Street Journal.
In a report citing people familiar with the negotiations, the paper said there is no guarantee that the acquisition will eventually happen, adding that regulators would likely need to review and sign off on any possible transaction due to antitrust concerns.
Seagen currently has a market capitalization of $30.14B and is expected to be worth a premium to that figure, the WSJ said.
Pfizer rival Merck (NYSE: MRK ) was in advanced talks with Seagen over an acquisition worth over $40B last year, but both sides were unable to reach a formal deal. The WSJ reported that Pfizer was also exploring a purchase at the time.
U.S.-based Seagen has helped develop a cancer treatment that targets tumors with toxic agents. By buying the company, Pfizer could expand its offering of cancer medicines and counter an anticipated $17B hit from patent expirations in 2030.
According to Reuters, Pfizer declined to comment and Seagen was not immediately available for comment.
Add Chart to Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
- Enrich the conversation
- Stay focused and on track. Only post material that’s relevant to the topic being discussed.
- Be respectful. Even negative opinions can be framed positively and diplomatically.
- Use standard writing style. Include punctuation and upper and lower cases.
- NOTE: Spam and/or promotional messages and links within a comment will be removed
- Avoid profanity, slander or personal attacks directed at an author or another user.
- Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
- Only English comments will be allowed.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.
Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb
Drop an image here or